Filgrastim biosimilar (Xiamen Amoytop Biotech)

非格司亭生物类似药（厦门特宝生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Xiamen Amoytop Biotech)

Drug Alias Name重组人粒细胞刺激因子（厦门特宝生物）rhG-CSF (Xiamen Amoytop Biotech)非格司亭生物仿制药（厦门特宝生物）TeerjinRecombinant human granulocyte macrophage colony stimulating factor (Xiamen Amoytop Biotech) +[8]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaNeutropenia

Original Approved Country/TerritoryMainland China

Original Approved Date1999/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesXiamen Amoytop Biotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesXiamen Amoytop Biotech Co Ltd

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02